Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccinations for travel abroad].

R Darioli1, B Braendli, F Holdener

  • 1Policlinique médicale universitaire, Lausanne.

Therapeutische Umschau. Revue Therapeutique
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026
Same author

Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

ESMO open·2025
Same author

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

ESMO open·2025
Same author

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

ESMO open·2025
Same author

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Swiss citizens traveling to developing countries face risks from vaccine-preventable diseases. This article provides updated vaccination recommendations for international travel, emphasizing personalized advice based on itinerary and health history.

Area of Science:

  • Travel Medicine
  • Infectious Disease Prevention
  • Public Health

Context:

  • Increasing travel by Swiss citizens to developing countries.
  • Pre-travel medical consultations are crucial for risk mitigation.

Purpose:

  • To provide updated recommendations on vaccines and immunoglobulins for international travelers.
  • To guide physicians in advising travelers based on itinerary and medical history.

Summary:

  • Reviews individual vaccine and immunoglobulin recommendations for travelers.
  • Highlights the importance of considering destination epidemiology and traveler's medical background.
  • Emphasizes personalized pre-travel health strategies.

Impact:

Related Experiment Videos

  • Aims to improve health outcomes for international travelers.
  • Supports healthcare providers in delivering effective pre-travel medical advice.
  • Contributes to the prevention of vaccine-preventable diseases in traveling populations.